Download presentation
Presentation is loading. Please wait.
Published byAlfhild Aas Modified over 5 years ago
1
Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis
Malena Cohen-Cymberknoh, Hannah Blau, David Shoseyov, Meir Mei-Zahav, Ori Efrati, Shoshana Armoni, Eitan Kerem Journal of Cystic Fibrosis Volume 8, Issue 4, Pages (July 2009) DOI: /j.jcf Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions
2
Fig. 1 a Change in FEV1% predicted in the IV methylprednisolone group. b Change in serum IgE levels in the IV methylprednisolone group. Journal of Cystic Fibrosis 2009 8, DOI: ( /j.jcf ) Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions
3
Fig. 2 a Change in FEV1% predicted in the PO prednisone group. b Change in serum IgE levels in the PO prednisone group. Journal of Cystic Fibrosis 2009 8, DOI: ( /j.jcf ) Copyright © 2009 European Cystic Fibrosis Society Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.